1,593 Shares in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Purchased by KBC Group NV
KBC Group NV bought a new stake in Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) in the fourth quarter, HoldingsChannel reports. The fund bought 1,593 shares of the company’s stock, valued at approximately $35,000. A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the […]
KBC Group NV bought a new stake in Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) in the fourth quarter, HoldingsChannel reports. The fund bought 1,593 shares of the company’s stock, valued at approximately $35,000. A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the […]
